Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | B. von Neubeck et al., Int. J. of Cancer, 2018, 143: 2065–2075, DOI: 10.1002/ijc.31607 | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., 2015, 290(29): 17894-17908; DOI 10.1074/jbc.M114.607184 | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | B. von Neubeck et al., Int. J. of Cancer, 2018, 143: 2065–2075, DOI: 10.1002/ijc.31607 | ||
MDA-MB-435S |
Human breast cancer metastatic melanoma cell line | ATCC HTB-129 | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | I. Karwaciak et al., Cancers, 2019, 11, 673, doi:10.3390/cancers11050673 | Link | |
MDA-MB-435S |
Human breast cancer metastatic melanoma cell line | ATCC HTB-129 | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | I. Karwaciak et al., Cancers, 2019, 11, 673, doi:10.3390/cancers11050673 | Link | |
MDA-MB-435S |
Human breast cancer cell line | ATCC HTB-129 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | K. Kemppainen et al., Cellular Signalling, 2016, 28: 1894–1903; doi.org/10.1016/j.cellsig.2016.09.004 | ||
MDA-MB-436 |
Human breast cancer cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MDA-MB-436 |
Human breast cancer cell line | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MDA-MB-468 |
Human breast adenocarcinoma cell line | ATCC HTB-132 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | publication | A. Ray et al., Mol. Cancer Res., Aug 2011; 9: 1030 - 1041 | Link | ||
MEC-2 |
Human chronic B cell leukemia cell line | DSMZ ACC500 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | S. W. Hofbauer et al., Cancer Res., Sep 2010; 70: 7336 - 7344 | Link | |
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. Notaro et al., Int. J. Biol. Sci., 2014, 10(5): 466-478, doi: 10.7150/ijbs.8337 | Link | |
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | D. Alcantara, PhD Thesis, 2012, University of Sussex | Link | |
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. Notaro et al., Int. J. of Oncology, 2016, 48: 1039-1044; DOI: 10.3892/ijo.2015.3307 | Link | |
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. D'Anneo et al., J. Cell. Physiol., 2013, 228: 952–967, DOI: 10.1002/jcp.24131 | ||
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Kerzendorfer et al., Hum. Mol. Genet., Apr 2010; 19: 1324 - 1334 | Link | |
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | sgRNA | CRISPR | Metafectene PRO | publication | C. Ren et al., J. Biol. Chem., Apr 2016; 291: 9629 - 9637 | Link | |
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | ||
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | C. Ren et al., J. Biol. Chem., Apr 2016; 291: 9629 - 9637 | Link | |
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Ren et al., J. Biol. Chem., Apr 2016; 291: 9629 - 9637 | Link | |
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Mol. Pharmacol., Oct 2014; 86: 561 - 569 | ||
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | ||
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | |
MKN45 |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | siRNA | RNA-Interference | Metafectene PRO | publication | S. V. Rao et al., BMC Cancer, 2017, 17:68, DOI 10.1186/s12885-017-3055-5 | Link |